Vitamin D analogues in psoriasis: effects on systemic calcium homeostasis

This publication has 28 references indexed in Scilit:

• Hypercalciuria and topical calcipotriol therapy
  British Journal of Dermatology, 2006
• Oral Calcium Tolerance Test in Extensive Psoriasis Treated with Topical Calcipotriol
  Dermatology, 1995
• Generalised pustular psoriasis: response to topical calcipotriol.
  BMJ, 1992
• Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris
  Journal of the American Academy of Dermatology, 1992
• Calcipotriol and hypercalcaemia
  Published by Elsevier ,1991
• Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
  The Lancet, 1991
• 1,25(OH)2D3 and calcipotriol (MC903) have similar effects on the induction of osteoclast-like cell formation in human bone marrow cultures
  Biochemical and Biophysical Research Communications, 1990
• A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis
  Journal of the American Academy of Dermatology, 1988
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
  Journal of Clinical Investigation, 1984
• Nuclear and cytoplasmic binding components for vitamin D metabolites
  Life Sciences, 1975